These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6099145)

  • 21. Characterization of guinea-pig high-molecular-weight kininogen as multi-functional molecule.
    Yamamoto T
    Biochim Biophys Acta; 1987 Aug; 914(3):259-74. PubMed ID: 3113483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High molecular weight kininogen is an inhibitor of platelet calpain.
    Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
    J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets.
    Jiang Y; Nawarawong W; Meloni FJ; Schmaier AH
    Thromb Haemost; 1992 Aug; 68(2):143-8. PubMed ID: 1412158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heavy chain of human high molecular weight and low molecular weight kininogens binds calcium ion.
    Higashiyama S; Ohkubo I; Ishiguro H; Sasaki M; Matsuda T; Nakamura R
    Biochemistry; 1987 Nov; 26(23):7450-8. PubMed ID: 3427086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet thrombospondin interactions with human high and low molecular weight kininogens.
    DeLa Cadena RA; Wyshock EG; Kunapuli SP; Schultze RL; Miller M; Walz DA; Colman RW
    Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant.
    Ben Nasr AB; Herwald H; Müller-Esterl W; Björck L
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):173-80. PubMed ID: 7826326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets.
    Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ
    Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human neutrophils contain and bind high molecular weight kininogen.
    Gustafson EJ; Schmaier AH; Wachtfogel YT; Kaufman N; Kucich U; Colman RW
    J Clin Invest; 1989 Jul; 84(1):28-35. PubMed ID: 2738152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T; Kato H; Maeda H; Iwanaga S
    J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-molecular-weight kininogen is a binding protein for tissue prokallikrein.
    Raab A; Kemme M
    FEBS Lett; 2000 Feb; 467(2-3):165-8. PubMed ID: 10675531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dexamethasone on kininogen production by a rat hepatoma cell line.
    Baussant T; Michaud A; Bouhnik J; Savoie F; Alhenc-Gelas F; Corvol P
    Biochem Biophys Res Commun; 1988 Aug; 154(3):1160-6. PubMed ID: 3408490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cell binding and thrombin inhibitory regions on kininogens' heavy chain.
    Jiang YP; Schmaier AH
    Agents Actions Suppl; 1992; 38 ( Pt 1)():233-40. PubMed ID: 1466275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen.
    Joseph K; Nakazawa Y; Bahou WF; Ghebrehiwet B; Kaplan AP
    Mol Med; 1999 Aug; 5(8):555-63. PubMed ID: 10501658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of inhibition of platelet calpain II by human kininogens.
    Bradford HN; Schmaier AH; Colman RW
    Biochem J; 1990 Aug; 270(1):83-90. PubMed ID: 2396995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.